Cor Vasa 2019, 61(5):464-470 | DOI: 10.33678/cor.2019.061

Retrospective analysis of factors influencing the results of surgical treatment of CLI: Effect of duration of ischemic defect

Peter Beňo, Marek Rusňák
Klinika cievnej chirurgie, Ústredná vojenská nemocnica Slovenského národného povstania, Fakultná nemocnica Ružomberok, Ružomberok, Slovakia

Introduction: Critical limb ischemia (CLI) has been considered to be one of the most serious medical, social and economic problems not only because of the threat of limb loss, but also because of the high long-term cardiovascular mortality. Therefore, CLI is currently very popular in the field of vascular medicine, as the subject of the research as well as a clinical problem. The basic conditions for the successful treatment of CLI are: complexity of the treatment based on the multidisciplinary consensus of all interested vascular specialists, and its timeliness.

Material and methodology: There were 109 surgically treated patients with CLI between 2011 and 2015 in our file. By retrospective analysis of CLI duration history data, patients were divided into two groups according to the timeliness of surgical revascularisation treatment. Based on the results of the treatment in both groups, we tried to determine the impact of the time on the success of the revascularisation in terms of the patency of the reconstruction and the salvage of the limb.

Keywords: Critical limb ischemia, Indications for surgical interventions, Peripheral arterial disease, Surgical treatment

Received: January 9, 2019; Accepted: August 23, 2019; Published: October 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beňo P, Rusňák M. Retrospective analysis of factors influencing the results of surgical treatment of CLI: Effect of duration of ischemic defect. Cor Vasa. 2019;61(5):464-470. doi: 10.33678/cor.2019.061.
Download citation

References

  1. Gergely P. High cardiovascular risk of the patient with critical limb ischemia-conservative management. Vasc Med 2011;3:95-97.
  2. Vidim T. Current options of surgical treatment of critical limb ischemia. Vasc Med 2011;3:103-105.
  3. Setacci C, Ricco JB; European Society for Vascular Surgery. Guidelines for critical limb ischemia and diabetic foot - introduction. Eur J Vasc Endovasc Surg 2011;42:S1-S30. Go to original source... Go to PubMed...
  4. Randon C, Jacobs B, De Ryck F, et al. Angioplasty or primary stenting for infrapopliteal lesions: results of a prospectiverandomized trial. Cardiovasc Intervent Radiol 2010;33:260-269. Go to original source... Go to PubMed...
  5. Balaz P, Rokosny S, Bafrnec J, Björck M. The role of hybrid procedures in the management of peripheral vascular disease. Scand J Surg 2012;101:232-237. Go to original source... Go to PubMed...
  6. Vinit NV, Melissa EH, Melina RK, et al. Critical limb ischaemia: Review articles. J Vasc Surg 2010;51:230-241. Go to original source... Go to PubMed...
  7. Slovut DP, Sullivan TM Critical limb ischemia: medical and surgical management. Vasc Med 2008;13:281-291. Go to original source... Go to PubMed...
  8. Menard MT, Belkin M. Aortoiliac disease direct reconstruction in Rutherfords Vascular Surgery, 7th edition, Saunders Elservier, 2010:1628 p. Go to original source...
  9. Šefránek V, Tomka J, Slyško R, Necpal R. Options of surgical treatment of critical limb ischemia of lower extremity. Vasc Med 2010;2:112-115.
  10. European Stroke Organisation, Tendera M, Aboyans V, et al. ESC guidelines on the diagnosis and treatment of peripheral artery disease. Eur Heart J 2011;32:2851-2906.
  11. Adam DJ, Beard JD, Clevelnad T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934. Go to original source... Go to PubMed...
  12. Conte MS, Bandyk DF, Clowes AW, et al. Results of PREVENT III: a multicenter, randomized trial of elifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43:742-750. Go to original source... Go to PubMed...
  13. Tomka J, Necpal R, et al. Surgical treatment of peripheral arterial disease of lower extremity and crirtical limb ischemia. Cardiology for practice 2013;2:86-90.
  14. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischaemia. J Vasc Surg 2008;47:975-981. Go to original source... Go to PubMed...
  15. Frankovičová M, et al. Our experience with reconstruction operations. Bratislava Medical Journal 1995;12:658-660.
  16. Šefránek V, et al. Lower extremity arterial disease and surgical treatment. SAP Bratislava 2011;89-185.
  17. Kudo T, Chandra FA, Kwun WH, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs open bypass surgery. J Vasc Surg 2006;44:304-313. Go to original source... Go to PubMed...
  18. Soderstrom M, Arvela E, Korhonen M, et al. Infrapopliteal percutaneous angioplasty versus bypass surgery as first-line strategies in critical leg ischemia a propensity scores analysis. Ann Surg 2010;252:765-773. Go to original source... Go to PubMed...
  19. Mills JL, et al. Section 15 - Lower Extremity Arterial Dissease (Chapter 109). In: Cronenwelt JL, et al. Rutherford's Vascular Surgery 7th edihion, Philadelphia: Elsevier, 2010:1682 p.
  20. Albers M, Romit M, Brochado-Neto FC, et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical limb ischemia. J Vasc Surg 2006;43:498-503. Go to original source... Go to PubMed...
  21. Noronen K, Saarinen E, Albäck A, Venermo M. Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patient require rapid reevascularisation. Eur J Vasc Endovasc Surg 2017;53:206-213. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.